
Novelcare
Novelcare is a YC Winter 2023 (W23) company. Based in New York, NY, USA; Remote. Team of 5.
About Novelcare
Summary
Novelcare connects physicians to clinical trials that match their existing patients, analyzing electronic health records to surface relevant, locally available studies at the point of care. It also works the other side: helping trial sites identify and reach eligible patients. The product replaces manual, ad-hoc recruitment outreach that leaves most doctors unaware of trials their patients qualify for.
Business model
Free for most practices, with revenue earned by practices through chart review fees on select studies.
Go-to-market
Novelcare sells to healthcare providers and clinical trial sites; physicians join through a self-serve onboarding flow, with study information delivered automatically into their existing clinical workflow.
From the Y Combinator listing
Empowering every doctor and every patient to participate in research
Novelcare addresses the primary bottleneck in drug development: recruiting patients into clinical trials. We analyze electronic health records to help doctors find clinical trials for their patients, and to help trial sites find patients for their studies. 72% of doctors want to inform their patients of clinical trials, but only 5% do. We're on a mission to close that gap, ultimately bringing safer, more effective drugs to the patients who need them.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- New York, NY, USA; Remote
- 5
- Active
- Early
Founders (2)
- Ethan Bond
- Jason Marmon
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works